Free Trial

SONOVA (OTCMKTS:SONVY) Upgraded to Strong-Buy at Sanford C. Bernstein

Sonova logo with Medical background

SONOVA (OTCMKTS:SONVY - Get Free Report) was upgraded by research analysts at Sanford C. Bernstein from a "hold" rating to a "strong-buy" rating in a research note issued on Friday,Zacks.com reports.

A number of other brokerages have also recently weighed in on SONVY. HSBC cut SONOVA from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Kepler Capital Markets upgraded SONOVA from a "strong sell" rating to a "hold" rating in a research report on Friday, June 6th. Hsbc Global Res cut SONOVA from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, May 21st. BNP Paribas cut SONOVA from a "strong-buy" rating to a "strong sell" rating in a research report on Wednesday, June 11th. Finally, Barclays cut SONOVA from a "hold" rating to a "strong sell" rating in a research report on Friday, June 20th. Four analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold".

Read Our Latest Research Report on SONVY

SONOVA Price Performance

SONVY traded up $0.72 on Friday, reaching $58.45. The company's stock had a trading volume of 20,047 shares, compared to its average volume of 30,623. SONOVA has a 1 year low of $52.83 and a 1 year high of $77.56. The company has a current ratio of 1.27, a quick ratio of 0.96 and a debt-to-equity ratio of 0.45. The business's 50 day moving average is $61.40 and its 200 day moving average is $62.33.

About SONOVA

(Get Free Report)

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

Read More

Analyst Recommendations for SONOVA (OTCMKTS:SONVY)

Should You Invest $1,000 in Sonova Right Now?

Before you consider Sonova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.

While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines